Pacer Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.49M | Sell |
326,098
-153,292
| -32% | -$3.52M | 0.02% | 561 |
|
|
2025
Q1 | $13.9M | Sell |
479,390
-870,978
| -64% | -$25.2M | 0.03% | 384 |
|
|
2024
Q4 | $50.1M | Buy |
1,350,368
+1,347,775
| +51,977% | +$50M | 0.11% | 198 |
|
|
2024
Q3 | $126K | Buy |
2,593
+1,666
| +180% | +$80.9K | ﹤0.01% | 1931 |
|
|
2024
Q2 | $37.1K | Buy |
927
+135
| +17% | +$5.4K | ﹤0.01% | 3268 |
|
|
2024
Q1 | $34.8K | Sell |
792
-178
| -18% | -$7.82K | ﹤0.01% | 3314 |
|
|
2023
Q4 | $60K | Sell |
970
-74
| -7% | -$4.58K | ﹤0.01% | 3052 |
|
|
2023
Q3 | $48K | Buy |
1,044
+16
| +2% | +$736 | ﹤0.01% | 2479 |
|
|
2023
Q2 | $59.1K | Buy |
+1,028
| New | +$59.1K | ﹤0.01% | 3053 |
|
|
2023
Q1 | – | Sell |
-231,009
| Closed | -$6.47M | – | 2199 |
|
|
2022
Q4 | $6.47M | Buy |
+231,009
| New | +$6.47M | 0.03% | 399 |
|
|
2022
Q3 | – | Sell |
-149,964
| Closed | -$5.22M | – | 2120 |
|
|
2022
Q2 | $5.22M | Buy |
+149,964
| New | +$5.22M | 0.04% | 361 |
|